To launch new drugs they undergo the number of test and process. Drug discovery technologies are used for the launch of new drugs and for research of drugs. The report on global drug discovery technologies market is an in-depth analysis of the segments and sub-segments in the drug discovery technologies market. The report provides analysis for the global as well as regional markets over the period of 2016 to 2024. According to the report the global drug discovery technologies market is expected to grow at a CAGR of 18.4% over the forecast period of 2018 - 2024.
The growing incidences of diseases, pathogen resistance to old drugs, patent expiries, and competition among drug manufacturers are the key factors that drive the growth of this market. Moreover, increasing investment in the field of nanotechnology, biotechnology, genomics, and, molecular biology are some other factor that has driven this market. Furthermore, the long duration of the drug discovery process, high initial setup cost and the presence of strict regulatory surroundings.
The report on global drug discovery technologies market covers segments such as technology type, and end users. The technology type segments include biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology, and others (RNAI, combinatorial chemistry). On the basis of end users the global drug discovery technologies market is categorized into biopharmaceutical companies, pharmaceutical companies, research institutes and biotech companies.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016 – 2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, and Malaysia among others. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018 - 2024.
The report provides profiles of the companies in the global drug discovery technologies market such as Agilent Technologies, Inc, Abbott Laboratories, Inc., GE Healthcare Ltd., Albany Molecular Research Inc., Affymetrix Inc., Arqule Inc., Luminex Corporation, Bayer Healthcare AG, Novartis AG, and AstraZeneca Plc.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global drug discovery technologies market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of drug discovery technologies market. Moreover, the study highlights current market trends and provides forecast from 2018 to 2024. We also have highlighted future trends in the drug discovery technologies market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. Additionally, the analysis highlights the rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors of the drug discovery technologies market to understand the present and future trends in this market and formulate their strategies accordingly.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter